TrueBlue Stock Forecast, Price & News

TrueBlue's stock was trading at $13.35 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TBI stock has increased by 51.1% and is now trading at $20.17.
View which stocks have been most impacted by COVID-19.

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" TrueBlue stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TBI, but not buy additional shares or sell existing shares.
View analyst ratings for TrueBlue or view MarketBeat's top 5 stock picks.

Wall Street analysts have given TrueBlue a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but TrueBlue wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

34 employees have rated TrueBlue CEO Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among TrueBlue's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

TrueBlue is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for TrueBlue.

TrueBlue will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

TrueBlue, Inc. (NYSE:TBI) announced its quarterly earnings results on Monday, October, 26th. The business services provider reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.22. The business services provider had revenue of $474.53 million for the quarter, compared to the consensus estimate of $453.92 million. TrueBlue had a negative net margin of 7.36% and a positive trailing twelve-month return on equity of 3.97%. TrueBlue's quarterly revenue was down 25.5% on a year-over-year basis. During the same period last year, the company posted $0.76 EPS.
View TrueBlue's earnings history.

5 brokers have issued twelve-month price objectives for TrueBlue's shares. Their forecasts range from $16.00 to $24.00. On average, they expect TrueBlue's share price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 10.8%.
View analysts' price targets for TrueBlue or view Wall Street analyst' top-rated stocks.

Some companies that are related to TrueBlue include Tradeweb Markets (TW), Robert Half International (RHI), ManpowerGroup (MAN), ASGN (ASGN), Insperity (NSP), Korn Ferry (KFY), Kforce (KFRC), Kelly Services (KELYA), Heidrick & Struggles International (HSII), Barrett Business Services (BBSI), GP Strategies (GPX) and Hudson Global (HSON).
View all of TBI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

TrueBlue's stock is owned by a number of retail and institutional investors. Top institutional investors include Exchange Traded Concepts LLC (0.18%), State of Alaska Department of Revenue (0.08%), Pacer Advisors Inc. (0.05%), Unison Advisors LLC (0.04%) and First Hawaiian Bank (0.04%). Company insiders that own TrueBlue stock include A Patrick Beharelle, Colleen B Brown, Derrek Lane Gafford, James E Defebaugh, Jeffrey B Sakaguchi and Taryn R Owen.
View institutional ownership trends for TrueBlue.

TBI stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue.
View insider buying and selling activity for TrueBlue or view top insider-selling stocks.

TBI stock was purchased by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, First Hawaiian Bank, Unison Advisors LLC, and Pacer Advisors Inc..
View insider buying and selling activity for TrueBlue or or view top insider-buying stocks.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $20.17.

TrueBlue has a market capitalization of $715.49 million and generates $2.37 billion in revenue each year. The business services provider earns $63.07 million in net income (profit) each year or $2.05 on an earnings per share basis. TrueBlue employs 6,200 workers across the globe.

The official website for TrueBlue is www.trueblue.com.

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]